Botox® resistance has identifiable triggers and formulation-level solutions. Here’s what aesthetic providers need to know about immunogenicity and management.

Setting prices for aesthetic treatments is different from billing insurance. Here’s a practical framework for benchmarking your market and building a fee structure that’s profitable.

A 2026 single-center observational study reports preliminary evidence that botulinum toxin may be deliverable transdermally for sebum reduction in oily and acne-prone skin. Here’s what the early data shows and what providers should watch for.